Veracyte (VCYT) Tops Q2 EPS by 8c, Beats on Revenue; Offers FY24 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. FMC
10. MRSH

Go back to Veracyte (VCYT) Tops Q2 EPS by 8c, Beats on Revenue; Offers FY24 Revenue Guidance

Veracyte Announces Second Quarter 2024 Financial Results

August 6, 2024 4:05 PM EDT

Grew total revenue to $114.4 million, an increase of 27%

Grew testing revenue by 31%

Conference call and webcast today at 4:30 p.m. ET

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the second quarter ended June 30, 2024.

Our exceptional second quarter results are a testament to the strength and robustness of Decipher and Afirma, said Marc Stapley, Veracytes chief executive officer. With both tests clearly gaining share in their respective markets and plenty of headroom for... More